How do you decide between the gene silencing drugs for familial amyloidosis with polyneuropathy?

The data to answer this question are very limited to non-existent, exactly because there have been no studies with a head-to-head comparison of the efficacy of different agents. Ultimately, it's a shared decision between the patient and the physician, which should take into account factors such as p...